Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-31 Sale |
2021-09-02 6:12 pm |
AbCellera Biologics Inc. | ABCL | HAMER JOHN Director |
300,000 | $16.94 | $5,082,253 | 14,734,623 (Indirect Direct) |
View |
| 2021-08-16 Purchase |
2021-08-17 5:47 pm |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
6,000 | $17.23 | $103,380 | 31,000 (Indirect Direct) |
View |
| 2021-06-22 Sale |
2021-06-22 6:50 pm |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
100,000 | $25.5 | $2,550,000 | 1,121,642 (Indirect) |
View |
| 2021-06-09 Sale |
2021-06-10 5:14 pm |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
5,598,420 | $24.03 | $134,530,033 | 55,604,330 (Direct) |
View |
| 2021-06-09 Sale |
2021-06-10 5:11 pm |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
6,000,000 | $24.13 | $144,770,323 | 233,500 (Indirect) |
View |
| 2021-06-09 Sale |
2021-06-10 5:01 pm |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
1,000,000 | $25.5 | $25,500,000 | 8,496,218 (Indirect Direct) |
View |
| 2021-06-09 Sale |
2021-06-10 5:01 pm |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
1,000,000 | $25.5 | $25,500,000 | 500 (Indirect Direct) |
View |
| 2021-06-09 Sale |
2021-06-10 5:00 pm |
AbCellera Biologics Inc. | ABCL | Falconer Ester Chief Technology Officer |
1,000,000 | $25.5 | $25,500,000 | 0 (Direct) |
View |
| 2021-06-09 Sale |
2021-06-10 5:00 pm |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
1,200,000 | $25.5 | $30,600,000 | 116,959 (Indirect Direct) |
View |
| 2020-12-15 Purchase |
2020-12-17 8:38 pm |
AbCellera Biologics Inc. | ABCL | THIEL PETER Director |
3,000,000 | $20 | $60,000,000 | 35,454,660 (Indirect) |
View |
| 2020-12-15 Purchase |
2020-12-17 8:30 pm |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
25,000 | $20 | $500,000 | 525,000 (Indirect Direct) |
View |
| 2020-12-15 Purchase |
2020-12-17 8:30 pm |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
23,000 | $20 | $460,000 | 11,687,018 (Indirect Direct) |
View |
| 2020-12-15 Purchase |
2020-12-17 8:30 pm |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
73,665 | $20 | $1,473,300 | 2,758,245 (Indirect Direct) |
View |
| 2020-12-15 Purchase |
2020-12-17 8:30 pm |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
500 | $20 | $10,000 | 1,041,300 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-18 Other |
2021-06-22 6:39 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | HAMER JOHN Director 10% Owner |
5,073,892 | $0 | 5,147,784 (Indirect) |
View |
| 2021-06-18 Other |
2021-06-22 6:13 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | DCVC Bio L.P. DCVC Bio GP LLC JNK Capital Management LLC ZNM Capital Management LLC Bogue Zachary Ocko Matthew Stead Kiersten 10% Owner |
5,073,892 | $0 | 5,147,784 (Indirect) |
View |
| 2021-06-15 Exercise |
2021-06-16 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
333,333 | $0.19 | 9,496,218 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-16 8:00 pm |
N/A 2027-03-23 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
333,333 | $0 | 9,496,218 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:30 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
250,000 | $2.3 | 2,850,500 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:30 pm |
N/A 2029-08-22 |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
1,000,000 | $0 | 2,850,500 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:30 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
750,000 | $0.32 | 2,850,500 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:30 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
600,000 | $0.19 | 6,566,959 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:30 pm |
N/A 2026-06-15 |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
1,200,000 | $0 | 6,566,959 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:30 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
600,000 | $0.32 | 6,566,959 (Direct) |
View |
| 2021-03-19 Exercise |
2021-04-23 8:00 pm |
N/A 2025-08-04 |
AbCellera Biologics Inc. | ABCL | Falconer Ester Chief Technology Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2021-03-19 Exercise |
2021-04-23 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Falconer Ester Chief Technology Officer |
1,000,000 | $0.0343 | 1,000,000 (Direct) |
View |
Ownership |
2021-02-05 8:00 pm |
N/A 2025-08-04 |
AbCellera Biologics Inc. | ABCL | Falconer Ester Chief Technology Officer |
0 | $0 | 3,530,800 (Direct) |
View |
| 2020-12-15 Conversion |
2020-12-17 8:45 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | DCVC Bio L.P. Bogue Zachary DCVC Bio GP LLC JNK Capital Management LLC Ocko Matthew Stead Kiersten ZNM Capital Management LLC 10% Owner |
32,513,396 | $0 | 29,105,761 (Indirect) |
View |
Ownership(A) |
2020-12-17 8:44 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | DCVC Bio L.P. DCVC Bio GP LLC ZNM Capital Management LLC Ocko Matthew Stead Kiersten Bogue Zachary JNK Capital Management LLC 10% Owner |
0 | $0 | 29,105,761 (Indirect) |
View |
| 2020-12-11 Option Award |
2020-12-17 8:38 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | THIEL PETER Director |
30,430,000 | $30,430,000 | 35,454,660 (Indirect) |
View |
| 2020-12-11 Option Award |
2020-12-17 8:38 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | THIEL PETER Director |
302,950 | $302,950 | 35,454,660 (Indirect) |
View |
| 2020-12-11 Option Award |
2020-12-17 8:38 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | THIEL PETER Director |
4,697,050 | $4,697,050 | 35,454,660 (Indirect) |
View |
| 2020-12-15 Conversion |
2020-12-17 8:38 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | THIEL PETER Director |
46,657,386 | $0 | 35,454,660 (Indirect) |
View |
| 2020-12-11 Option Award |
2020-12-17 8:35 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | HAMER JOHN Director 10% Owner |
500,000 | $500,000 | 29,605,761 (Indirect) |
View |
| 2020-12-15 Conversion |
2020-12-17 8:35 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | HAMER JOHN Director 10% Owner |
32,513,396 | $0 | 29,605,761 (Indirect) |
View |
| 2020-11-18 Option Award |
2020-12-17 8:30 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
500,000 | $0 | 525,000 (Direct) |
View |
| 2020-10-29 Option Award |
2020-12-17 8:30 pm |
N/A 2030-10-29 |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
2,190,800 | $0 | 11,687,018 (Direct) |
View |
| 2020-11-06 Exercise |
2020-12-17 8:30 pm |
N/A 2029-09-11 |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
270,000 | $0 | 2,758,245 (Indirect) |
View |
| 2020-12-15 Conversion |
2020-12-17 8:30 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
2,117,647 | $0 | 2,758,245 (Indirect) |
View |
| 2020-11-06 Exercise |
2020-12-17 8:30 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
270,000 | $0.33 | 2,758,245 (Indirect) |
View |
| 2020-11-18 Option Award |
2020-12-17 8:30 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
100,000 | $0 | 2,758,245 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-17 8:30 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
2,000,000 | $2,000,000 | 2,758,245 (Indirect) |
View |
| 2020-10-29 Option Award |
2020-12-17 8:30 pm |
N/A 2030-10-29 |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
1,040,800 | $0 | 1,041,300 (Direct) |
View |
Ownership |
2020-12-11 9:24 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | DCVC Bio L.P. DCVC Bio GP LLC ZNM Capital Management LLC Ocko Matthew Stead Kiersten Bogue Zachary 10% Owner |
0 | $0 | 29,105,761 (Indirect) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | THIEL PETER Director |
0 | $0 | 11,360,427 (Indirect) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hayden Michael R Director |
0 | $0 | 1,787,977 (Indirect) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner |
0 | $0 | 67,045,140 (Indirect) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A 2029-08-22 |
AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer |
0 | $0 | 3,040,800 (Direct) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | HAMER JOHN Director 10% Owner |
0 | $0 | 29,105,761 (Indirect) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A 2030-11-18 |
AbCellera Biologics Inc. | ABCL | Montalbano John S. Director |
0 | $0 | 500,000 (Direct) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer |
0 | $0 | 6,795,759 (Indirect) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer |
0 | $0 | 12,664,018 (Indirect) |
View |
Ownership |
2020-12-11 8:00 pm |
N/A N/A |
AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner |
0 | $0 | 61,202,750 (Direct) |
View |